{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:52:30Z","timestamp":1760237550572,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ecl.2010.02.005","type":"journal-article","created":{"date-parts":[[2010,6,5]],"date-time":"2010-06-05T04:33:33Z","timestamp":1275712413000},"page":"355-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vitamin D in Kidney Disease: Pathophysiology and the Utility of Treatment"],"prefix":"10.1016","volume":"39","author":[{"given":"Rizwan A.","family":"Qazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ecl.2010.02.005_bib1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"issue":"113","key":"10.1016\/j.ecl.2010.02.005_bib2","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ecl.2010.02.005_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.005_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/j.ecl.2010.02.005_bib5","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2010.02.005_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2362.2006.01665.x","article-title":"Vascular calcification and renal osteodystrophy relationship in chronic kidney disease","volume":"36","author":"Moe","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.005_bib7","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1046\/j.1523-1755.2002.00634.x","article-title":"Expression profiling confirms the role of endocytic receptor megalin in renal vitamin D3 metabolism","volume":"62","author":"Hilpert","year":"2002","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.005_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00041433-200206000-00004","article-title":"Pathways for kidney-specific uptake of the steroid hormone 25-hydroxyvitamin D3","volume":"13","author":"Willnow","year":"2002","journal-title":"Curr Opin Lipidol"},{"issue":"24","key":"10.1016\/j.ecl.2010.02.005_bib9","doi-asserted-by":"crossref","first-page":"13895","DOI":"10.1073\/pnas.241516998","article-title":"Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3)","volume":"98","author":"Nykjaer","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.005_bib10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0002-9440(10)65238-8","article-title":"Megalin knockout mice as an animal model of low molecular weight proteinuria","volume":"155","author":"Leheste","year":"1999","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.005_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","article-title":"An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3","volume":"96","author":"Nykjaer","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.005_bib12","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"10.1016\/j.ecl.2010.02.005_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","article-title":"Hypovitaminosis D in medical inpatients","volume":"338","author":"Thomas","year":"1998","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.005_bib14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","article-title":"Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study","volume":"24","author":"Gonzalez","year":"2004","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.005_bib15","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States","volume":"45","author":"LaClair","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.005_bib16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/jn\/114.7.1313","article-title":"Defective photoproduction of cholecalciferol in normal and uremic humans","volume":"114","author":"Jacob","year":"1984","journal-title":"J Nutr"},{"issue":"12","key":"10.1016\/j.ecl.2010.02.005_bib17","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.005_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.ecl.2010.02.005_bib19","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/sj.ki.5002532","article-title":"Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis","volume":"72","author":"Usatii","year":"2007","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.005_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.005_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI118061","article-title":"Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins","volume":"96","author":"Patel","year":"1995","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.ecl.2010.02.005_bib22","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J\u00a0Clin Invest"},{"issue":"4 Suppl 1","key":"10.1016\/j.ecl.2010.02.005_bib23","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1053\/ajkd.2001.27394","article-title":"Vascular calcification and inorganic phosphate","volume":"38","author":"Giachelli","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.005_bib24","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.005_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1681\/ASN.2007080854","article-title":"Mechanisms of vascular calcification in chronic kidney disease","volume":"19","author":"Moe","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.005_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2007.04.010","article-title":"Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD","volume":"50","author":"Al-Aly","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.005_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000098561","article-title":"Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease","volume":"27","author":"Zisman","year":"2007","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.005_bib28","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V105980","article-title":"Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone","volume":"10","author":"Finch","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.005_bib29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","article-title":"A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia","volume":"26","author":"Slatopolsky","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.005_bib30","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems","volume":"288","author":"Xiang","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"43","key":"10.1016\/j.ecl.2010.02.005_bib31","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1073\/pnas.0611202104","article-title":"Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals","volume":"104","author":"Bodyak","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.005_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ki.2008.101","article-title":"Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice","volume":"74","author":"Zhou","year":"2008","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.005_bib33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.005_bib34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.005_bib35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.ki.5001542","article-title":"Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study","volume":"70","author":"Melamed","year":"2006","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.ecl.2010.02.005_bib36","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.005_bib37","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.005_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2007.110","article-title":"Association of activated vitamin D treatment and mortality in chronic kidney disease","volume":"168","author":"Kovesdy","year":"2008","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.005_bib39","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ecl.2010.02.005_bib40","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archinte.168.12.1340","article-title":"Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality","volume":"168","author":"Dobnig","year":"2008","journal-title":"Arch Inter Med"},{"issue":"5768","key":"10.1016\/j.ecl.2010.02.005_bib41","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.005_bib42","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/596314","article-title":"Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis","volume":"48","author":"Gombart","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.005_bib43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/jsre.2001.6221","article-title":"1,25-(OH(2))D(3) alters the transforming growth factor beta signaling pathway in renal tissue","volume":"100","author":"Aschenbrenner","year":"2001","journal-title":"J Surg Res"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.005_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000052615","article-title":"1,25-Dihydroxyvitamin D3 differentially regulates IL-1alpha-stimulated IL-8 and MCP-1 mRNA expression and chemokine secretion by human primary proximal tubular epithelial cells","volume":"9","author":"Kruger","year":"2001","journal-title":"Exp Nephrol"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.005_bib45","doi-asserted-by":"crossref","first-page":"F526","DOI":"10.1152\/ajprenal.00316.2003","article-title":"1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat","volume":"286","author":"Kuhlmann","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.005_bib46","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1681\/ASN.2006091028","article-title":"Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats","volume":"18","author":"Mizobuchi","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.005_bib47","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1046\/j.1523-1755.1998.00951.x","article-title":"Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats","volume":"53","author":"Schwarz","year":"1998","journal-title":"Kidney Int"},{"issue":"19","key":"10.1016\/j.ecl.2010.02.005_bib48","doi-asserted-by":"crossref","first-page":"15741","DOI":"10.1074\/jbc.M011033200","article-title":"Cross-talk between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta signaling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements","volume":"276","author":"Subramaniam","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.005_bib49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.ki.5002572","article-title":"Renoprotective role of the vitamin D receptor in diabetic nephropathy","volume":"73","author":"Zhang","year":"2008","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.005_bib50","first-page":"62","article-title":"Effects of calcitriol and its analogues on interaction of MCP-1 and monocyte derived dendritic cells in vitro","volume":"22","author":"Zhu","year":"2001","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.005_bib51","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.005_bib52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","article-title":"Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial","volume":"54","author":"Fishbane","year":"2009","journal-title":"Am J Kidney Dis"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852910000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852910000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:35:25Z","timestamp":1760175325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852910000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0889852910000071"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2010.02.005","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D in Kidney Disease: Pathophysiology and the Utility of Treatment","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2010.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}